Compass Point Research has doubled down on skepticism around Coinbase, maintaining a $140 price target that sits substantially below recent valuations. The research firm's bearish stance centers on a structural challenge that has intensified over the past 18 months: the company's struggle to compete effectively in derivatives trading, a market segment where institutional players and specialized platforms have captured disproportionate market share and margin.
The derivatives landscape has undergone a seismic shift since Coinbase went public in 2021. Platforms like Deribit, OKX, and Bybit have aggressively built out perpetual futures offerings with deeper liquidity, tighter spreads, and more sophisticated risk management tools. Meanwhile, traditional finance heavyweights including CME and crypto-native venues have fragmented what was once Coinbase's historical advantage in on-ramp liquidity. For retail and institutional traders, the calculus has shifted: spot trading on Coinbase remains convenient, but derivatives execution increasingly happens elsewhere. This dynamic directly threatens Coinbase's revenue diversification strategy, which has relied on scaling derivatives volume to offset margin compression in core spot trading.
The $140 target implies meaningful downside from where the stock has traded recently, signaling that Compass Point believes the market has yet to fully price in structural headwinds. More critically, Coinbase's regulatory relationship with the SEC—which has cast uncertainty over whether certain products qualify as securities—creates additional friction that pure derivatives specialists don't face. The company cannot simply build faster or cheaper; it must navigate compliance frameworks that competitors operating in gray zones have sidestepped. This compliance burden is a feature, not a bug, from a risk perspective, but it constrains the velocity at which Coinbase can innovate relative to less-regulated rivals.
What makes the Compass Point thesis noteworthy is its specificity: this isn't generic macro skepticism but rather a targeted assessment of competitive moat erosion in a critical revenue stream. For investors, the question isn't whether Coinbase remains viable, but whether its valuation justifies the growth constraints imposed by both regulatory friction and entrenched competition in higher-margin product categories. As institutional capital continues fragmenting across specialized venues, Coinbase's leverage to the crypto ecosystem may prove thinner than its equity premium suggests.